Vimarsana
Biggest News Aggregation in the World

Page 43 - Sciences Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Corp Today - Breaking & Trending Today

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Regent Peak Wealth Advisors LLC - Vimarsana News

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Regent Peak Wealth Advisors LLC

Regent Peak Wealth Advisors LLC cut its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 4.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,604 shares of the medical research company’s stock after selling 578 shares during the […]

Exact Sciences Co. (NASDAQ:EXAS) EVP Sarah Condella Sells 1,000 Shares - Vimarsana News

Exact Sciences Co. (NASDAQ:EXAS) EVP Sarah Condella Sells 1,000 Shares

Exact Sciences Co. (NASDAQ:EXAS – Get Rating) EVP Sarah Condella sold 1,000 shares of Exact Sciences stock in a transaction on Monday, May 1st. The stock was sold at an average price of $63.78, for a total transaction of $63,780.00. Following the completion of the sale, the executive vice president now owns 86,401 shares of […]

Exact Sciences Co. (NASDAQ:EXAS) EVP Sarah Condella Sells 1,000 Shares - Vimarsana News

Exact Sciences Co. (NASDAQ:EXAS) EVP Sarah Condella Sells 1,000 Shares

Exact Sciences Co. (NASDAQ:EXAS – Get Rating) EVP Sarah Condella sold 1,000 shares of Exact Sciences stock in a transaction on Monday, May 1st. The shares were sold at an average price of $63.78, for a total value of $63,780.00. Following the completion of the sale, the executive vice president now owns 86,401 shares in […]

Exact Sciences Co. (NASDAQ:EXAS) Receives Average Rating of "Moderate Buy" from Brokerages - Vimarsana News

Exact Sciences Co. (NASDAQ:EXAS) Receives Average Rating of "Moderate Buy" from Brokerages

Exact Sciences Co. (NASDAQ:EXAS – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price […]

Exact Sciences to participate in May investor conference - Vimarsana News

Exact Sciences to participate in May investor conference

MADISON, Wis., May 1, 2023 /PRNewswire/ -- Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the... | May 1, 2023